MedKoo Cat#: 575172 | Name: Ranitidine bismuth citrate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Ranitidine bismuth citrate is a non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers. It is commonly used in treatment of peptic ulcer disease, gastroesophageal reflux disease, and Zollinger–Ellison syndrome.

Chemical Structure

Ranitidine bismuth citrate
Ranitidine bismuth citrate
CAS#128345-62-0 (bismuth citrate)

Theoretical Analysis

MedKoo Cat#: 575172

Name: Ranitidine bismuth citrate

CAS#: 128345-62-0 (bismuth citrate)

Chemical Formula: C19H27BiN4O10S

Exact Mass: 712.1252

Molecular Weight: 712.48

Elemental Analysis: C, 32.03; H, 3.82; Bi, 29.33; N, 7.86; O, 22.46; S, 4.50

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Synonym
Azamplus; Elicodil; Helirad; Pylorisan; Ranitidine bismuth citrate; Tritec
IUPAC/Chemical Name
1,2,3-Propanetricarboxylic acid, 2-hydroxy-, bismuth(3(+)) salt (1:1), compd. with N-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine (1:1)
InChi Key
XAUTYMZTJWXZHZ-UHFFFAOYSA-K
InChi Code
InChI=1S/C13H22N4O3S.C6H8O7.Bi/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3;7-3(8)1-6(13,5(11)12)2-4(9)10;/h4-5,9,14-15H,6-8,10H2,1-3H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);/q;;+3/p-3
SMILES Code
[Bi+3].CNC(=C[N+](=O)[O-])NCCSCc1oc(CN(C)C)cc1.OC(CC(=O)[O-])(CC(=O)[O-])C(=O)[O-]
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 712.48 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Selbes M, Beita-Sandí W, Kim D, Karanfil T. The role of chloramine species in NDMA formation. Water Res. 2018 Apr 16;140:100-109. doi: 10.1016/j.watres.2018.04.033. [Epub ahead of print] PubMed PMID: 29702375. 2: de Araújo ERD, Guerra GCB, Araújo DFS, de Araújo AA, Fernandes JM, de Araújo Júnior RF, da Silva VC, de Carvalho TG, Ferreira LS, Zucolotto SM. Gastroprotective and Antioxidant Activity of Kalanchoe brasiliensis and Kalanchoe pinnata Leaf Juices against Indomethacin and Ethanol-Induced Gastric Lesions in Rats. Int J Mol Sci. 2018 Apr 24;19(5). pii: E1265. doi: 10.3390/ijms19051265. PubMed PMID: 29695040. 3: Allen SJ, Chazot PL, Dixon CJ. Can H(2) -receptor upregulation and raised histamine explain an anaphylactoid reaction on cessation of ranitidine in a 19-year-old female? A case report. Br J Clin Pharmacol. 2018 Apr 18. doi: 10.1111/bcp.13578. [Epub ahead of print] PubMed PMID: 29667234. 4: Kennedy L, Hargrove L, Demieville J, Karstens A, Jones H, DeMorrow S, Meng F, Invernizzi P, Bernuzzi F, Alpini G, Smith S, Akers A, Meadows V, Francis H. Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2(-/-) mice and human cholangiocarcinoma tumorigenesis. Hepatology. 2018 Mar 30. doi: 10.1002/hep.29898. [Epub ahead of print] PubMed PMID: 29601088.